Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (A 26-year retrospective analysis)

Blood

Volumn 92, Issue 8, 1998, Pages 2742-2749

  Stucki, Anne ^a   Leisenring, Wendy ^a   Sandmaier, Brenda M ^a   Sanders, Jean ^a   Anasetti, Claudio ^a   Storb, Rainer ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD3; PROCARBAZINE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032532040     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.8.2742.420k19_2742_2749     Document Type: Article

References (49)

1. Lum LG, Seigneuret MC, Doney KC, Storb R: In vitro immunoglobulin production, proliferation, and cell markers before and after antithymocyte globulin therapy in patients with aplastic anemia. Am J Hemato 126:1, 1987
2. Elfenbein GJ, Kallman CH, Tutschka PJ, Adkinson NF Jr, Bias WB, Braine HG, Humphrey RL, Saral R, Mellits ED, Santos GW: The immune system in 40 aplastic anemia patients receiving conventional therapy. Blood 53:652, 1979
3. Santos GW, Owens AH Jr: Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant Proc 1:44, 1969
4. Storb R, Epstein RB, Rudolph RH, Thomas ED: Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation 7:378, 1969
5. Storb R, Buckner CD, Dillingham LA, Thomas ED: Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res 30:2195, 1970
6. Thomas ED, Buckner CD, Storb R, Neiman PE, Fefer A, Clift RA, Slichter SJ, Funk DD, Bryant JI, Lerner KG: Aplastic anaemia treated by marrow transplantation. Lancet 1:284, 1972
7. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL: Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Ann Intern Med 92:30, 1980
8. Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman P: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43:157, 1974
9. Storb R, Prentice RL, Thomas ED: Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296:61, 1977
10. Ramsay NKC, Kim T, Nesbit ME, Krivit W, Coccia PF, Levitt SH, Woods WG, Kersey JH: Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 55:344, 1980
11. UCLA Bone Marrow Transplant Team, Gale RP, Cline MJ, Fahey JL, Feig S, Opelz G, Young L, Territo M, Golde D, Sparkes R, Naeim F, Juillard G, Haskell C, Fawzi F, Sarna G, Falk P: Bone-marrow transplantation in severe aplastic anaemia. Lancet 2:921, 1976
12. van Bekkum DW, Bach F, Bergan JJ, Bortin MM, Buckley RH, Good RA, Graw RGJ, Levey R, Mathe G, Rimm AA, Santos G: Bone marrow transplantation from histocompatible, allogeneic donors for aplastic anemia. A report from the ACS/NIH bone marrow transplant registry. JAMA 236:1131, 1976
13. Elfenbein GJ, Anderson PN, Klein DL, Schacter BZ, Santos GW: Difficulties in predicting bone-marrow graft rejection in patients with aplastic anemia. Transplant Proc 10:441, 1978
14. Sanders JE, Storb R, Anasetti C, Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Hansen J: Marrow transplant experience for children with severe aplastic anemia. Am J Ped Hematol Oncol 16:43, 1994
15. Niederwieser D, Pepe M, Storb R, Loughran TP Jr, Longton G, for the Seattle Marrow Transplant Team: Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anemia. Br J Haematol 69:23, 1988
16. Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M, Holley G, Yam P, Petz L, Winston DJ, Feig SA: Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy. Transplantation 49:720, 1990
17. Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C, Speck B, Bortin MM: Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 73:606, 1989
18. Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM, Musaoka T, Ramsay NKC, Rimm AA, Rozman C, Sobocinski KA, Speck B, Bortin MM: Bone marrow transplantation for severe aplastic anemia: Influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 79:269, 1992
19. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, Flowers M, Hansen J, Martin P, Pepe M, Sale G, Sanders J, Singer J, Sullivan KM, Thomas ED, Witherspoon RP: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941, 1994
20. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89:3048, 1997
21. Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Fernando LP, Giblett ER, Goodell BW, Johnson FL, Lerner KG, Neiman PE, Sanders JE: Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 48:817, 1976
22. Deeg HJ. Shulman HM, Schmidt E, Yee GC, Thomas ED, Storb R: Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with Cyclophosphamide and cyclosporine. Transplantation 42:497, 1986
23. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton G, Lum L, Martin P, McGuffin R, Sanders J, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED: Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68:119, 1986
24. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versushost disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295, 1974
25. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
26. Doney KC, Weiden PL, Storb R, Thomas ED: Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1, 1981
27. Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD, Clift RA, Doney KC, Hansen J, Martin PJ, Sanders JE, Stewart P, Witherspoon RP, Thomas ED: Second marrow transplants in patients with aplastic anemia rejecting the first graft: Use of a conditioning regimen including Cyclophosphamide and antithymocyte globulin. Blood 70:116, 1987
28. Bjerke JW, Lorenz J, Martin PJ, Storb R, Hansen JA, Anasetti C: Treatment of graft failure with anti-CD3 antibody BC3, glucocorticoids and infusion of donor hematopoietic cells. Blood 86:107a, 1995 (abstr, suppl 1)
29. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
30. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
31. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
32. Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, Chauncey T, Clift RA, Deeg HJ, Doney KC, Flowers MED, Hansen JA, Martin PJ, Sanders JE, Sullivan KM, Witherspoon RP: Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin (letter). Blood 89:3890, 1997
33. Storb R, Epstein RB, Rudolph RH, Thomas ED: The effect of prior transfusion on marrow grafts between histocompatible canine siblings. J Immunol 105:627, 1970
34. Storb R, Rudolph RH, Graham TC, Thomas ED: The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings. J Immunol 107:409, 1971
35. Anasetti C, Doney KC, Storb R, Meyers JD, Farewell VT, Buckner CD, Appelbaum FR, Sullivan KM, Clift RA, Deeg HJ, Fefer A, Martin PJ, Singer JW, Sanders JE, Stewart PS, Witherspoon RP, Thomas ED: Marrow transplantation for severe aplastic anemia: Long term outcome in fifty "untransfused" patients. Ann Intern Med 104:461, 1986
36. Storb R, Deeg HJ, Weiden PL, Graham TC, Atkinson KA, Slichter SJ, Thomas ED: Marrow graft rejection in DLA-identical canine littermates: Antigens involved are expressed on leukocytes and skin epithelial cells but probably not on platelets and red blood cells. Transplant Proc 11:504, 1979
37. Bean MA, Storb R, Graham T, Raff R, Sale GE, Schuening F, Appelbaum FR: Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood. Transplantation 52:956, 1991
38. Bean MA, Graham T, Appelbaum FR, Deeg HJ, Schuening F, Sale GE, Storb R: Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts. Transplantation 57:423, 1994
39. Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236, 1982
40. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FR, Sanders JE, Stewart PS, Thomas ED: Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98:461, 1983
41. Gluckman E, Socie G, Devergie A, Bourdeau-Esperou H, Traineau R, Cosset JM: Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoracoabdominal irradiation for conditioning: Long-term follow-up. Blood 78:2451, 1991
42. Feig SA, Champlin R, Arenson E, Yale C, Ho W, Tesler A, Gale RP: Improved survival following bone marrow transplantation for aplastic anaemia. Br J Haematol 54:509, 1983
43. McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NKC: Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood 70:1325, 1987
44. Gluckman E, Devergie A, Meletis J, Traineau R, Vilmer E, Lehn E, Keable H, Bourrhis JH, Varrin F: Bone marrow transplantation in severe aplastic anaemia. Report of 97 consecutive patients. Bone Marrow Transplant 2:101, 1987
45. Crawford SW, Longton G, Storb R: Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 12:225, 1993
46. Deeg HJ. Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R: Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 87:386, 1996
47. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM. Witherspoon RP, Thomas ED: Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 6:813, 1988
48. Sanders JE, Buckner CD, Sullivan KM, Doney K, Appelbaum F, Witherspoon R, Anasetti C, Storb R, Thomas ED: Growth and development after bone marrow transplantation, in Buckner CD, Gale RP, Lucarelli G (eds): Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches. New York, NY, Liss, 1989, p 375
49. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87:3045, 1996